Showing 671-680 of 854 results for "".
- Laser Surgery Lawsuits May be Less Likely with Physician Operatorshttps://modernaesthetics.com/news/laser-surgery-lawsuits-may-be-less-likely-with-physician-operators/2473208/The majority of liability claims due to a cutaneous laser surgery device between 2012 and 2020 involved a non-physician operator, according to a new study in the March 2022 issue of Dermatologic Surgery. Researchers analyzed cases of liability claims due to a cutaneou
- Galderma Launches Alastin Skincare® ReFORM & RePAIR COMPLEXhttps://modernaesthetics.com/news/galderma-launches-alastin-skincare-reform-repair-complex/2473199/Galderma has launched Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology®. Designed to be used pre- and post-surgery to create an optimal environment for recovery, ReFORM & RePAIR COMPLEX with TriHex Technology® aims to help accelerate the recovery proc
- Aesthetics Biomedical Expands Vivace and SoME Skincare Ambassadorship Programhttps://modernaesthetics.com/news/aesthetics-biomedical-expands-vivace-and-some-skincare-ambassadorship-program/2473177/Aesthetics Biomedical Inc. (ABM) has expanded its Vivace & SoME Skincare Ambassadorship Program, which brings notable plastic surgeons, dermatologists, medical aesthetic practitioners, and skincare professionals together with two fast growing aestheti
- Galderma to Acquire Alastin Skincarehttps://modernaesthetics.com/news/galderma-to-acquire-alastin-skincare/2473169/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- 1 Million and Counting: Emsculpt Marks Treatment Milestonehttps://modernaesthetics.com/news/1-million-and-counting-emsculpt-marks-treatment-milestone/2473166/The Emsculpt family of products from BTL is the fastest aesthetic device brand to reach one million treatments, as indicated by Medical Insights. According to BTL, which reported the milestone, an average of 21 Emsculpt Classic treatments/unit a
- NeoGenesis Products Expand Beyond Oncology Skin Carehttps://modernaesthetics.com/news/neogenesis-products-expand-beyond-oncology-skin-care/2473164/NeoGenesis’ science-based skin and hair products have expanded from oncology aftercare to management of chronic skin conditions, aesthetic concerns, and wound support. The products were developed to provide a safe, natural approach to improving the quality of life of those undergoing oncolo
- Coming in November: The Science of Skincare Summithttps://modernaesthetics.com/news/coming-in-november-the-science-of-skincare-summit/2473146/A one-day event dedicted to education on skincare for medical and aesthetic professionals in all specialties, the Science of Skincare Summit November 6 at JW Marriott Essex House in New York City. Dermatologists Patti Farris, MD and Ted Lain, MD are co-founders of the program,
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc
- Study Tracks Increased Sadness, Fear, Disgust Among Healthcare Workers Linked to COVID-19https://modernaesthetics.com/news/study-tracks-increased-sadness-fear-disgust-among-healthcare-workers-linked-to-covid-19/2473134/Researchers discovered patterns of significantly decreased joy, increased sadness, fear and disgust among health care professionals (HCP) during the COVID-19 pandemic. The study, led by researchers at Ben-Gurion University of the
- ellacor from Cytrellis Cleared for Moderate-to-Severe Facial Wrinkleshttps://modernaesthetics.com/news/ellacor-from-cytrellis-cleared-for-moderate-to-severe-facial-wrinkles/2473129/FDA has cleared the ellacor system from Cytrellis for the treatment of moderate-to-severe wrinkles in the mid to lower face. The minimally invasive device, featuring Micro-Coring technology, is a first-in-category device that safely removes micro-sized portions of excess